Skip to main content

Table 3 Univariate analysis of primary predictors of 3-y ILD-related events

From: ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases

IPF group

   

Variable

Hazard ratio

95% CI

P

Age

1.025

0.915–1.154

0.669

Sex (Male)

1.464

0.128–16.780

0.754

Monocyte ratio

1.466

1.027–2.206

0.035

Honeycomb score

1.078

0.741–1.491

0.663

GGO score

0.994

0.710–1.349

0.971

ILD-GAP score

0.757

0.241–1.970

0.583

%FVC

0.972

0.925–1.015

0.206

%DLco

0.991

0.954–1.022

0.590

Non-IPF group

   

Variable

Hazard ratio

95% CI

P

Age

0.978

0.900–1.074

0.617

Sex (Male)

0.337

0.067–1.707

0.183

Monocyte ratio

1.063

0.861–1.266

0.538

Honeycomb score

1.221

0.657–1.844

0.449

GGO score

0.953

0.713–1.189

0.713

ILD-GAP score

2.130

1.044–4.174

0.038

%FVC

0.990

0.954–1.026

0.587

%DLco

1.000

0.972–1.026

0.990

  1. Abbreviations: CI confidence interval, GAP gender/age/physiology, GGO ground-glass opacity, ILD interstitial lung disease, IPF idiopathic pulmonary fibrosis, %DLco percentage predicted diffusion capacity of lung for carbon monoxide, %FVC percentage predicted forced vital capacity